99 results
Page 2 of 5
8-K
EX-99.1
qh0ycq 7jhv83x
17 Jun 22
Other Events
4:57pm
424B3
622z9pguo32yvppr908c
1 Jun 22
Prospectus supplement
4:06pm
8-K
EX-10.1
rrfbz7vppftjzvya9gks
20 May 22
Celularity Inc. Announces $30 Million Private Placement
4:06pm
8-K
EX-99.1
8udz 4bowq
20 May 22
Celularity Inc. Announces $30 Million Private Placement
4:06pm
424B3
uge xone4
16 May 22
Prospectus supplement
8:20pm
8-K
EX-99.1
pie3sw av5j6t9
16 May 22
Celularity Reports First Quarter 2022 Financial Results and Provides Corporate Update
4:47pm
424B3
kke0p2idt0kt
3 May 22
Prospectus supplement
4:06pm
POS AM
kc3lgckzgs242 5gq
1 Apr 22
Prospectus update (post-effective amendment)
9:15pm
8-K
EX-99.1
l98t63o
31 Mar 22
Celularity Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
4:06pm
424B3
gdppq154
16 Feb 22
Prospectus supplement
8:36am
8-K
EX-99.1
yjy699 ih1pn
16 Feb 22
Other Events
8:31am
424B3
ufiy0rn9iaas 67s4
18 Jan 22
Prospectus supplement
4:11pm
8-K
EX-99.1
842tsuozavrdbi1
18 Jan 22
Other Events
4:06pm
424B3
v2gszu7badoubb8
28 Dec 21
Prospectus supplement
4:05pm
8-K
EX-99.1
i4urycbxsg7g1s1a17s7
28 Dec 21
Celularity Receives Fast Track Designation from U.S. FDA for its NK Cell Therapy CYNK-001 in Development for the Treatment of AML
4:01pm
424B3
pwnao9efddwm6l
12 Nov 21
Prospectus supplement
4:45pm